ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap.

about

ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap.

Item

http://www.wikidata.org/entity/Q49215238

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap.

@en

ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap.

@nl

type

Item

label

ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap.

@en

ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap.

@nl

prefLabel

ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap.

@en

ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap.

@nl

P1476

ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap

@en

P2093

Adeera Levin

http://www.w3.org/2001/XMLSchema#string

Alberto Fierro

http://www.w3.org/2001/XMLSchema#string

Andreas Radbruch

http://www.w3.org/2001/XMLSchema#string

Andrew Rees

http://www.w3.org/2001/XMLSchema#string

Anne Davidson

http://www.w3.org/2001/XMLSchema#string

Brad Rovin

http://www.w3.org/2001/XMLSchema#string

Catherine Meyer-Schwesinger

http://www.w3.org/2001/XMLSchema#string

Chaim Putterman

http://www.w3.org/2001/XMLSchema#string

Charles Pusey

http://www.w3.org/2001/XMLSchema#string

David Jayne

http://www.w3.org/2001/XMLSchema#string

P2860

The need for randomization in animal trials: an overview of systematic reviews

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

The Efficacy and Safety of Leflunomide for the Treatment of Lupus Nephritis in Chinese Patients: Systematic Review and Meta-Analysis

Pro: 'The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism--individual patient variability in disease presentation, course and response to therapy

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial

Data gaps limit the translational potential of preclinical research.

Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.

P304

327-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EKIR.2016.06.009

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P932

5720527

http://www.w3.org/2001/XMLSchema#string